Are New Therapies on the Horizon for Painful Skin Condition?
UCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
University of California San Francisco
Give to UCSF
Sandy Feng Elected to the National Academy of Medicine for 2023
UCSF transplant surgeon Sandy Feng, MD, PhD, has been elected to the National Academy of Medicine, one of the most prestigious organizations in health and medicine.
Tragic Loss, Health Merge in New Work from UCSF Artist in Residence
Katina Bitsicas, UCSF’s newest Artist in Residence, is embarking on an immersive project aimed at creating “a visual representation of the destruction that’s happening in our bodies and ecosystems” connected to the common herbicide glyphosate.
UCSF’s Diana Greene Foster Selected as a 2023 MacArthur Fellow
Diana Greene Foster, leader of a groundbreaking study on what happens to women who are denied abortions, has been named a 2023 MacArthur Fellow, one of the most coveted honors in academia, science and the arts.
Fading Eyesight Helps UCSF’s Angela Woon Find ‘Saving Grace’
Angela Woon, an IT Communications Analyst at UCSF, avid runner, and writer, shares her story and experience with Retinitis Pigmentosa (RP), a condition that will eventually cause her sight to fully deteriorate.
Brief Dialysis May Be Best for Some Kidney Patients
Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.
Can a Simple Fentanyl Test Curb San Francisco’s Overdose Crisis?
With fentanyl overdose deaths at an all-time high, a successful UCSF-funded pilot project to distribute fentanyl test strips is being expanded by California Gov. Gavin Newsome as part of his plan to address the crisis.
An AirPod-Sized Wearable That Can Relieve Kids’ Gut Pain
A small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).
UCSF Research Vital to First Drug for Deadly Bone Disease
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
Will a Pill Help New Moms Bounce Back from Postpartum Depression?
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
